Angiotensin-converting enzyme gene polymorphism in Behçet's disease

Area of Science:

• Genetics and Immunology
• Vascular Biology
• Rheumatology

Background:

• Endothelial dysfunction is central to Behçet's disease (BD).
• The renin-angiotensin system (RAS), regulated by angiotensin-converting enzyme (ACE), influences vascular tone and inflammation.
• The ACE gene's I/D polymorphism's role in BD pathogenesis is unexplored.

Purpose of the Study:

• To investigate the ACE gene I/D polymorphism distribution in BD patients.
• To determine if this polymorphism correlates with clinical manifestations of BD, including ocular, neurological, and vascular involvement.

Main Methods:

• Genotyping for ACE I/D polymorphism in 90 BD patients and 30 healthy controls.
• Statistical analysis to compare genotype frequencies between groups.
• Correlation analysis between ACE genotypes and BD clinical phenotypes.

Main Results:

• No significant difference in ACE genotype (DD, ID, II) distribution between BD patients and controls.
• The ACE gene polymorphism was not associated with ocular, neurological, or vascular manifestations in BD.
• No significant difference in allele frequencies between the groups.

Conclusions:

• The ACE gene I/D polymorphism does not appear to contribute to the pathogenesis of Behçet's disease.
• Neither the D nor the I allele of the ACE gene influences the development of major BD clinical features.